Market Chameleon (Thu, 18-Jun 7:44 AM ET)
Market Chameleon (Wed, 17-Jun 6:30 AM ET)
Azitra Announces Strategic Shift Toward Cosmetics and Biotech Tools
TipRanks (Wed, 17-Jun 8:35 AM ET)
PRNewswire (Wed, 17-Jun 8:01 AM ET)
Azitra, Inc. to Present at 2026 BIO International Convention
PRNewswire (Tue, 16-Jun 5:29 PM ET)
Azitra Expands Authorized Shares Following Stockholder Approvals
TipRanks (Tue, 16-Jun 8:53 AM ET)
Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting
PRNewswire (Thu, 4-Jun 4:05 PM ET)
Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting
PRNewswire (Wed, 27-May 4:30 PM ET)
Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates
PRNewswire (Wed, 13-May 8:30 AM ET)
Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program
PRNewswire (Wed, 6-May 5:34 PM ET)
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.
Azitra trades on the AMEX stock market under the symbol AZTR.
As of June 18, 2026, AZTR stock price declined to $0.17 with 27,835,700 million shares trading.
AZTR has a beta of 1.39, meaning it tends to be more sensitive to market movements. AZTR has a correlation of 0.03 to the broad based SPY ETF.
AZTR has a market cap of $2.78 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, AZTR traded as high as $1,034.97 and as low as $.10.
AZTR has underperformed the market in the last year with a price return of -90.2% while the SPY ETF gained +26.9%. However, in the short term, AZTR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +25.6% vs +13.5% return in SPY. But in the last 2 weeks, AZTR shares have been beat by the market, returning -21.2% compared to an SPY return of -1.1%.
AZTR support price is $.19 and resistance is $.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AZTR shares will trade within this expected range on the day.
